Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

Thoma Bravo to take HR software provider Dayforce private

Reuters on MSN · 2d
Dayforce to go private in $12.3 billion Thoma Bravo acquisition
Private equity firm Thoma Bravo has agreed to buy human resources software provider Dayforce for $12.3 billion, including debt, in a take-private deal that executives hope will help expand on the company's AI capabilities.
SiliconANGLE · 2d
Thoma Bravo to take HR software provider Dayforce private for $12.3B
Dayforce Inc. today announced that it has agreed to be acquired by private equity firm Thoma Bravo for $12.3 billion.
The Wall Street Journal · 4d
Thoma Bravo in Talks to Acquire Dayforce for Around $11 Billion
A deal would see the private-equity firm pay $70 a share for the human-resources software company, a 7% premium to Tuesday’s closing price.
2don MSN

Goldman Sachs pledges $6B debt package for Thoma Bravo's Dayforce takeover - report

Goldman Sachs (NYSE:GS) has lined up a $6B debt financing package to back private equity firm Thoma Bravo's acquisition of HR ...
5d

Private Equity Powerhouse Eyes Dayforce in Billion-Dollar Deal

Private equity giant Thoma Bravo is reportedly circling Dayforce, a $1.76B cloud HCM leader, in what could be a landmark deal ...
6don MSN

A buyout firm reportedly has Dayforce in its sights. Shares of the HR software group are soaring.

Buyout firm Thoma Bravo could announce a deal in the next few weeks to take Dayforce private, Bloomberg reported on Monday, citing sources.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy